---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021265"
form_type: "8-K"
ticker: "GNLX"
cik: "0001231457"
company_name: "GENELUX Corp"
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:36:41.280905+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Genelux prices $27.5M offering of 6.875M shares and warrants at $4.00

## Summary
- Gross proceeds ~$27.5M; net ~$25.4M from 6,875,000 shares and 6,875,000 warrants at combined $4.00/unit.
- Each warrant exercisable at $5.25, immediately exercisable, expires 5 years from issuance.
- Underwriters granted 30-day option for additional 1,031,250 shares and warrants (15% over-allotment).
- Proceeds to fund working capital into Q1 2026 and Olvi-Vec development; Phase 3 OnPrime topline expected H2 2025.
- Closing expected May 29, 2024; Guggenheim Securities sole bookrunner, Newbridge Securities co-manager.

## SEC filing metadata
- accession: 0001493152-24-021265
- form_type: 8-K
- ticker: GNLX
- cik: 0001231457
- company_name: GENELUX Corp
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1231457/000149315224021265/0001493152-24-021265-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1231457/000149315224021265/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021265
- JSON: https://secwatch.observer/filing/0001493152-24-021265.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021265.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.